Cover Image

Therapy of thyroid carcinoma with the histone deacetylase inhibitor MS-275

Purpose: Dysregulation of histone acetylation associated with an up-regulation of histone deacetylase (HDAC) activity is common in malignant tumours. Therefore, HDAC inhibitors were developed whose effects on proliferation and apoptosis have been shown in different tumour entities. Since non-iodide-...

Full description

Saved in:
Bibliographic Details
Main Authors: Altmann, Annette (Author) , Eisenhut, Michael (Author) , Bauder-Wüst, Ulrike (Author) , Markert, Annette (Author) , Askoxylakis, Vasileios (Author) , Hess-Stumpp, Holger (Author) , Haberkorn, Uwe (Author)
Format: Article (Journal)
Language:English
Published: 03 August 2010
In: European journal of nuclear medicine and molecular imaging
Year: 2010, Volume: 37, Issue: 12, Pages: 2286-2297
ISSN:1619-7089
DOI:10.1007/s00259-010-1573-3
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00259-010-1573-3
Get full text
Author Notes:Annette Altmann, Michael Eisenhut, Ulrike Bauder-Wüst, Annette Markert, Vasileios Askoxylakis, Holger Hess-Stumpp, Uwe Haberkorn

MARC

LEADER 00000caa a2200000 c 4500
001 1823165362
003 DE-627
005 20240326080310.0
007 cr uuu---uuuuu
008 221122s2010 xx |||||o 00| ||eng c
024 7 |a 10.1007/s00259-010-1573-3  |2 doi 
035 |a (DE-627)1823165362 
035 |a (DE-599)KXP1823165362 
035 |a (OCoLC)1389822668 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Altmann, Annette  |e VerfasserIn  |0 (DE-588)1032267984  |0 (DE-627)738189111  |0 (DE-576)379930099  |4 aut 
245 1 0 |a Therapy of thyroid carcinoma with the histone deacetylase inhibitor MS-275  |c Annette Altmann, Michael Eisenhut, Ulrike Bauder-Wüst, Annette Markert, Vasileios Askoxylakis, Holger Hess-Stumpp, Uwe Haberkorn 
264 1 |c 03 August 2010 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 22.11.2022 
520 |a Purpose: Dysregulation of histone acetylation associated with an up-regulation of histone deacetylase (HDAC) activity is common in malignant tumours. Therefore, HDAC inhibitors were developed whose effects on proliferation and apoptosis have been shown in different tumour entities. Since non-iodide-concentrating thyroid carcinomas represent a therapeutic problem, this study addressed the effects of the HDAC inhibitor MS-275 on thyroid carcinoma cells. Methods: After the antiproliferative effect of MS-275 had been proven in different human and rat thyroid carcinoma cell lines, FRO82-2, SW1736 and FTC133 cells were further investigated with respect to changes in apoptosis, cell cycle and metabolism by the annexin V/propidium iodide assay, FACS analysis and uptake experiments employing 3-O-methyl-D-(3H)glucose, fluoro-2-deoxy-D-glucose2 [5,6-3H] and 14C-aminoisobutyric acid (AIB). The induction of iodide transport and gene expression were investigated in 125iodide uptake experiments and real-time polymerase chain reaction (PCR). Results: MS-275 induced a concentration- and time-dependent inhibition of proliferation in the thyroid carcinoma cell lines with varying IC50 values. In FRO82-2, SW1736 and FTC133 cells characterized by low, moderate and high sensitivity an up-regulation of p21CIP/WAF1 expression and G1 and/or G2 phase arrest were observed upon MS-275 exposure corresponding to the sensitivity of individual cell lines. In addition, high MS-275 concentrations increased the apoptotic cell fraction of FTC133 and SW1736 cells, whereas resistance to apoptosis and simultaneous up-regulation of Bcl-2 gene expression were observed in FRO82-2 cells. MS-275 treatment also mediated a concentration-dependent decrease of 3H-FDG uptake and an increased 3-O-methyl-D-(3H)glucose uptake in all thyroid carcinoma cell lines after 24 h, an increased uptake of both tracers in FTC133 cells after 48 h, and restored the functional activity of the sodium-iodide symporter in SW1736 and FTC133 cells up to 20- and 45-fold. Conclusion: MS-275 exerts dose-dependent antiproliferative effects including growth arrest, differentiation and apoptosis in some thyroid carcinoma cell lines and might, therefore, be considered for the treatment of anaplastic and non-iodide-concentrating thyroid carcinomas. 
650 4 |a Apoptosis 
650 4 |a Histone deacetylase inhibitor 
650 4 |a Iodide uptake 
650 4 |a p21CIP/WAF1 expression 
650 4 |a Thyroid carcinoma 
700 1 |a Eisenhut, Michael  |e VerfasserIn  |0 (DE-588)1113306122  |0 (DE-627)867174501  |0 (DE-576)160846080  |4 aut 
700 1 |a Bauder-Wüst, Ulrike  |e VerfasserIn  |4 aut 
700 1 |a Markert, Annette  |e VerfasserIn  |4 aut 
700 1 |a Askoxylakis, Vasileios  |e VerfasserIn  |4 aut 
700 1 |a Hess-Stumpp, Holger  |e VerfasserIn  |4 aut 
700 1 |a Haberkorn, Uwe  |d 1959-  |e VerfasserIn  |0 (DE-588)1022913905  |0 (DE-627)717331245  |0 (DE-576)366166352  |4 aut 
773 0 8 |i Enthalten in  |t European journal of nuclear medicine and molecular imaging  |d Heidelberg [u.a.] : Springer-Verl., 2002  |g 37(2010), 12, Seite 2286-2297  |h Online-Ressource  |w (DE-627)359787258  |w (DE-600)2098375-X  |w (DE-576)110279549  |x 1619-7089  |7 nnas  |a Therapy of thyroid carcinoma with the histone deacetylase inhibitor MS-275 
773 1 8 |g volume:37  |g year:2010  |g number:12  |g pages:2286-2297  |g extent:12  |a Therapy of thyroid carcinoma with the histone deacetylase inhibitor MS-275 
856 4 0 |u https://doi.org/10.1007/s00259-010-1573-3  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20221122 
993 |a Article 
994 |a 2010 
998 |g 1022913905  |a Haberkorn, Uwe  |m 1022913905:Haberkorn, Uwe  |d 910000  |d 911400  |e 910000PH1022913905  |e 911400PH1022913905  |k 0/910000/  |k 1/910000/911400/  |p 7  |y j 
998 |g 1113306122  |a Eisenhut, Michael  |m 1113306122:Eisenhut, Michael  |d 50000  |e 50000PE1113306122  |k 0/50000/  |p 2 
998 |g 1032267984  |a Altmann, Annette  |m 1032267984:Altmann, Annette  |d 910000  |d 911400  |e 910000PA1032267984  |e 911400PA1032267984  |k 0/910000/  |k 1/910000/911400/  |p 1  |x j 
999 |a KXP-PPN1823165362  |e 4218132429 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title":"Therapy of thyroid carcinoma with the histone deacetylase inhibitor MS-275","title_sort":"Therapy of thyroid carcinoma with the histone deacetylase inhibitor MS-275"}],"name":{"displayForm":["Annette Altmann, Michael Eisenhut, Ulrike Bauder-Wüst, Annette Markert, Vasileios Askoxylakis, Holger Hess-Stumpp, Uwe Haberkorn"]},"note":["Gesehen am 22.11.2022"],"person":[{"given":"Annette","display":"Altmann, Annette","roleDisplay":"VerfasserIn","family":"Altmann","role":"aut"},{"given":"Michael","roleDisplay":"VerfasserIn","display":"Eisenhut, Michael","family":"Eisenhut","role":"aut"},{"display":"Bauder-Wüst, Ulrike","roleDisplay":"VerfasserIn","given":"Ulrike","family":"Bauder-Wüst","role":"aut"},{"role":"aut","family":"Markert","display":"Markert, Annette","roleDisplay":"VerfasserIn","given":"Annette"},{"role":"aut","family":"Askoxylakis","roleDisplay":"VerfasserIn","display":"Askoxylakis, Vasileios","given":"Vasileios"},{"family":"Hess-Stumpp","role":"aut","roleDisplay":"VerfasserIn","display":"Hess-Stumpp, Holger","given":"Holger"},{"given":"Uwe","roleDisplay":"VerfasserIn","display":"Haberkorn, Uwe","role":"aut","family":"Haberkorn"}],"id":{"eki":["1823165362"],"doi":["10.1007/s00259-010-1573-3"]},"recId":"1823165362","relHost":[{"id":{"issn":["1619-7089"],"zdb":["2098375-X"],"eki":["359787258"]},"pubHistory":["29.2002 -"],"recId":"359787258","title":[{"title":"European journal of nuclear medicine and molecular imaging","title_sort":"European journal of nuclear medicine and molecular imaging","subtitle":"official journal of the European Association of Nuclear Medicine (EANM)"}],"note":["Gesehen am 13.02.2023","Ungezählte Beil.: Supplement"],"disp":"Therapy of thyroid carcinoma with the histone deacetylase inhibitor MS-275European journal of nuclear medicine and molecular imaging","language":["eng"],"part":{"text":"37(2010), 12, Seite 2286-2297","pages":"2286-2297","issue":"12","extent":"12","volume":"37","year":"2010"},"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"publisher":"Springer-Verl.","dateIssuedDisp":"2002-","publisherPlace":"Heidelberg [u.a.]","dateIssuedKey":"2002"}],"physDesc":[{"extent":"Online-Ressource"}]}],"physDesc":[{"extent":"12 S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedDisp":"03 August 2010","dateIssuedKey":"2010"}],"language":["eng"]} 
SRT |a ALTMANNANNTHERAPYOFT0320 

Similar Items